The cough variant asthma

Cover Page

Cite item

Full Text

Abstract

Cough variant asthma (CVA) was first described by W. Corrao. CVA was described as the isolated chronic cough as the only presenting symptom responsive to bronchodilator therapy.This phenotype of asthma is present with airway hyperresponsiveness, eosinophilic inflammation airways and bronchodilator responsive coughing without typical manifestation of asthma such as wheezing or dyspnea. CVA shares common features with classic asthma such as eosinophilic inflammation and airway remodeling. Because of that, CVA is clinically considered as a variant type of asthma.

About the authors

M. O. Uryasjev

Ryazan State Medical University

Email: docib@yandex.ru
ORCID iD: 0000-0001-8693-4696

д.м.н., проф., зав. каф. факультетской терапии с курсом терапии ФДПО

Russian Federation, Ryazan

I. V. Ponomareva

Ryazan State Medical University

Author for correspondence.
Email: docib@yandex.ru
ORCID iD: 0000-0002-0273-4388

к.м.н., доц. каф. факультетской терапии с курсом терапии ФДПО

Russian Federation, Ryazan

M. F. Bhar

Ryazan State Medical University

Email: docib@yandex.ru
ORCID iD: 0000-0001-6721-4634

аспирант каф. факультетской терапии с курсом терапии ФДПО

Russian Federation, Ryazan

S. I. Glotov

Ryazan State Medical University

Email: docib@yandex.ru
ORCID iD: 0000-0002-4445-4480

доц. каф. факультетской терапии с курсом терапии ФДПО

Russian Federation, Ryazan

References

  1. Исаева И.А., Урясьев О.М., Чунтыжева Е.Г. и др. Эффективность применения комплексов физических факторов у больных бронхиальной астмой с сопутствующей гипертонической болезнью. Наука молодых (Eruditio Juvenium). 2018;6(1):63-73 [Isaeva IA, Uryasyev OM, Chuntyzheva EG, et al. Effectiveness of application of complexes of physical factors in patients with bronchial asthma and comorbid essential hypertension. Nauka molodykh (Eruditio Juvenium) (In Russ.)]. doi: 10.23888/HMJ2018163-73
  2. Рогачиков А.И., Урясьев О.М. Техника ингаляции лекарственных средств и контроль над бронхиальной астмой. Российский медико-биологический вестник им. академика И.П. Павлова. 2016;24(3):86-91 [Rogachikov AI, Uryas’ev OM. The medication inhale technology and asthma control. Rossiiskii Mediko-Biologicheskii Vestnik im. akademika I.P. Pavlova. 2016;24(3):86-91 (In Russ.)]. doi: 10.17816/PAVLOVJ2016386-91
  3. Niimi A Geography and cough a etiology. Pulm Pharmacol Ther. 2007;20:383-7. doi: 10.1016/j.pupt.2006.10.014
  4. Marsden PA, Smith JA, Kelsall AA, et al. A comparison of objective and subjective measures of cough in asthma. J Allergy Clin Immunol. 2008;122:5903-7. doi: 10.1016/j.jaci.2008.08.029
  5. Corrao W, Braman S, Irwin R. Chronic cough as the sole presenting manifestation of bronchial asthma. N Engl J Med. 1979;300:633-7. doi: 10.1056/nejm197903223001201
  6. Niimi A, Matsumoto H, Mishima M. Eosinophilic airway disorders associated with chronic cough. Pulm Pharmacol Ther. 2009;22:114-20. doi: 10.1016/j.pupt.2008.12.001
  7. Braman S, Corrao W. Chronic cough. Diagnosis and treatment. Prim Care. 1985;12:217-25. doi: 10.3928/0090-4481-19960301-09
  8. Birring SS, Parker D, Brightling CE, et al. Induced sputum inflammatory mediator concentrations in chronic cough. Am J Respir Crit Care Med. 2004;169(1):15-9. doi: 10.1164/rccm.200308-1092OC
  9. Niimi A. Cough variant asthma: a major cause of chronic cough. Clin Pulm Med. 2008;15:189-96. doi: 10.1097/cpm.0b013e31817e3059
  10. Rabe KF, Adachi M, Lai CK, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol. 2004;114:40-7. doi: 10.1016/j.jaci. 2004.04.042
  11. Arakawa H, Hamasaki Y, Kohno Y, et al. Japanese guidelines for childhood asthma 2017. Allergol Inter. 2017;66(2):190-204. doi: 10.1016/j.alit.2016.11.003
  12. Niimi A, Matsumoto H, Takemura M, et al. Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am J Respir Crit Care Med. 2003;168(8):983-8. doi: 10.1164/rccm.200211-1268OC
  13. Fujimura M, Ogawa H, Nishizawa Y, Nishi K: Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma? Thorax. 2003;58:14-8. doi: 10.1136/thorax.58.1.14
  14. Ioan I, Poussel M, Coutier L, et al. What is chronic cough in children? Front Physiol. 2014;5:322. doi: 10.3389/FPHYS.2014.00322
  15. Niimi A. Cough and asthma. Cur Respir Med Rev. 2011;7(1):47-54. doi: 10.2174/15733981179410932
  16. Morjaria B, Kastelik A. Unusual asthma syndromes and their management. Ther Advanc Chron Dis. 2011;2(4):249-64. doi: 10.1177/2040622311407542
  17. Masayuki H, Motoyasu I, Manabu S, Haruhito S. Smart Therapy for the initial treatement for cough variant asthma could lead to the improvement of adherence to therapy. Respirology. 2017;22:88-278. doi: 10.1111/resp.13207_215
  18. Fujimura M, Hara J, Myou S. Change in bronchial responsiveness and cough reflex sensitivity in patients with cough variant asthma: Effect of inhaled corticosteroids. Cough. 2005;I:5. doi: 10.1186/1745-9974-1-5
  19. De Diego A, Martinez E, Perpina M, et al. Airway inflammation and cough sensitivity in cough-variant asthma. Allergy. 2005;60(11):1407-11. doi: 10.1111/j.1398-9995.2005.00609
  20. Kanazawa H, Eguchi Y, Nomura N, Yoshikawa J. Analysis of vascularendothelialgrowth factor levels in inducedsputumsamplesfrom patients withcough variant asthma. Ann Allergy, Asthma Immunol. 2005;95(3):266-71. doi: 10.1016/S1081-1206(10)61224
  21. Liu M, Liu K, Zhu N, et al. Inflammatory mediators in induced sputum and airway hyperresponsiveness in cough variant asthma during long-term inhaled corticosteroid treatment. Mediat Inflamm. 2012;2012:403868. doi: 10.1155/2012/403868
  22. Mochizuki H, Arakawa H, Tokuyama K, Morikawa A. Bronchial sensitivity and bronchial reactivity in children with cough variant asthma. Chest. 2005;128(4):2427-34. doi: 10.1378/chest.128.4.2427
  23. Masayuki H, Motoyasu I, Manabu S, Haruhito S. SmartTherapy for the initial treatement for cough variant asthma could lead to the improvement of adherence to therapy. Respirology. 2017;22:88-278. doi: 10.1111/resp.13207_215
  24. Asano T, Takemura M, Fukumitsu K, et al. Diagnostic utility of fractional exhaled nitric oxide in prolonged and chronic cough according to atopic status. Allergol Intern. 2017;66(2):344-50. doi: 10.1016/j.alit.2016.08.015
  25. Shimoda T, Obase Y, Kishikawa R, et al. The fractional exhaled nitric oxide and serum high sensitivity C-reactive protein levels in cough variant asthma and typical bronchial asthma. Allergol Intern. 2013;62(2):251-7. doi: 10.2332/allergolint.12-OA-0515
  26. Ichinose M, Sugiura H, Nagase H, et al. Japanese guidelines for adult asthma 2017. Allergol Intern. 2017;66(2):163-89. doi: 10.1016/j.alit.2016.12.005
  27. Magni C, Chellini E, Zanasi A. Cough variant asthma and atopic cough. Multidisciplinary Respir Med. 2010;5(2):99-103. doi: 10.1186/2049-6958-5-2-99
  28. Sridaran S, Gonzalez-Estrada A, Aronica AM. A case of cough variant asthmaundiagnosed for 16 years. Operation and Maintenance Center – Radio. 2014;2014(2):29-30. doi: 10.1093/omcr/omu012
  29. Terasaki G, Paauw DS. Evaluation and treatment of chronic cough. Med Clin North Am. 2014;98(3):391-403. doi: 10.1016/j.mcna.2014.01.002
  30. Takemura M, Niimi A, Matsumoto H, et al. Clinical, physiological and anti-inflammatoryeffects of montelukast in patients withcough variant asthma. Respiration. 2012;83:308-1. doi: 10.1159/000332835

Copyright (c) 2020 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies